Cogstate (ASX: CGS) — Company Overview, News & Financial Data
Cogstate focuses on developing digital cognitive assessment tools for researchers and clinicians globally to assess cognitive function.
Cogstate
Cogstate is a neuroscience and technology company specializing in digital cognitive assessment tools and clinical trial endpoint management services. Headquartered in Melbourne, Australia, the company develops standardized computerized tests and cloud-based software to measure cognitive function in biopharmaceutical clinical trials and clinical care. Cogstate offers solutions including rater training, endpoint data quality monitoring, direct-to-patient remote cognitive evaluations, and scientific consulting. Its platforms support research and drug development across diverse therapeutic indications such as Alzheimer's disease, Parkinson's disease, schizophrenia, major depressive disorder, pediatric rare diseases, and oncology.
Snapshot
Operations
Products and/or services of Cogstate
- Digital Cognitive Assessment: Standardized computerized cognitive tests administered on digital devices to measure domain-specific brain functions such as memory, attention, and executive function in biopharmaceutical clinical trials and clinical care settings across global research sites.
- Endpoint Data Quality Services: Comprehensive clinician rater training, certification, and audio or video data quality monitoring programs designed to maintain consistent scale administration and reduce scoring variability across international clinical trial study centers.
- Remote Cognitive Assessment: Direct-to-patient decentralized clinical trial solutions and virtual assessment protocols enabling at-home self-administration and remote monitoring of cognitive performance across decentralized biopharmaceutical clinical trials and longitudinal healthcare research studies.
- Healthcare Cognitive Screening: Digital brain health assessment tools and clinical care platforms designed for physicians, healthcare providers, and patients to detect, monitor, and track early cognitive changes in routine clinical settings.
- Scientific Consulting Services: Specialized advisory services providing neuroscientific expertise, clinical trial design, protocol development, cognitive battery selection, and statistical analysis support for pharmaceutical and biotechnology companies developing neuroscience therapeutic candidates.
- Research and Academic Collaborations: Provision of digital cognitive testing platforms, standardized outcome measures, and specialized data management support for investigator-initiated clinical studies, university medical research programs, and non-commercial academic research projects globally.
Cogstate executive team
- Mr. Bradley John O'Connor B.Bus, C.A.CEO, MD & Executive Director
- Mr. Darren WatsonChief Financial Officer
- Dr. Pamela Ventola Ph.D.Chief Science Officer
- Ms. Rachel ColiteExecutive VP of Clinical Trials
- Prof. Paul Maruff BBSc (Hons), Ph.D.Founder & Chief Innovation Officer
- Ms. Kristi Geddes L.L.B.General Counsel, Joint Company Secretary & Director
- Mr. Kenneth BillardChief Commercial Officer
- Dr. Kaycee Sink M.D.Chief Medical Officer
- Mr. David James Franks BEc, C.A., F Fin, J.P.Joint Company Secretary